Surfactant downregulates synthesis of DNA and inflammatory mediators in normal human lung fibroblasts

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 270, Issue 1 14-1, 1996, Pages

  Thomassen, Mary Jane ^a   Antal, Joyce M ^a   Barna, Barbara P ^a   Divis, Lisa T ^a   Meeker, David P ^a   Wiedemann, Herbert P ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

adult respiratory distress syndrome; antioxidant; cytokine; prostaglandin E2

Indexed keywords

ACETYLCYSTEINE; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; LUNG SURFACTANT; MENADIONE; PROSTAGLANDIN E2; SURFACTANT;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; DNA SYNTHESIS; DOWN REGULATION; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; INFLAMMATION; LUNG FIBROBLAST; ONCOGENE C FOS; PRIORITY JOURNAL;

EID: 0030064518     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1996.270.1.l159     Document Type: Article

References (33)

1. Baeuerle, P. A., and T. Henkel. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol 12: 141-179, 1994.
2. Baldin, V., J. Likas, M. J. Marcote, M. Pagano, J. Bartek, and G. Draetta. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7: 812-821, 1993.
3. Bitterman, P. B. Pathogenesis of fibrosis in acute lung injury. Am. J. Med. 92 Suppl. 6A: 39S-43S, 1992.
4. Brigham, K. L. Oxidant stress and adult respiratory distress syndrome. Eur. Respir. J. 3 Suppl. 11: 482S-484S, 1990.
5. Foldes-Filep, E., P. Sirois, and J. G. Filep. Pulmonary surfactant lipids inhibit prostanoid production of guinea pig alveolar macrophages. J. Leukocyte Biol. 56: 475-480, 1994.
6. Geertsma, M. F., W. L. Teeuw, P. H. Nibbering, and R. Van Furth. Pulmonary surfactant inhibits activation of human monocytes by recombinant interferon-γ. Immunology 82: 450-456, 1994.
7. Ghio, A, J., P. J. Fracica, S. L. Young, and C. A. Piantadosi. Synthetic surfactant scavenges oxidants and protects against hyperoxic lung injury. J. Appl. Physiol. 77: 1217-1223, 1994.
8. Gregory, T. J., W. J. Longmore, M. A. Moxley, J. A. Whitsett, C. R. Reed, A. A. Fowler, L. D. Hudson, R. J. Maunder, C. Crim, and T. M. Hyers. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J. Clin. Invest. 88: 1976-1981, 1991.
9. Hallman, M., R. Spragg, J. H. Harrell, K. M. Moser, and L. Gluck. Evidence of lung surfactant abnormality in respiratory failure. J. Clin. Invest. 70: 673-683, 1982.
10. Kovary, K., and R. Bravo. Expression of different jun and fos proteins during GO to G1 transition in mouse fibroblasts: in vitro and in vivo associations. Mol. Cell. Biol. 11: 2451-2459, 1991.
11. Kovary, K., and R. Bravo. The jun and fos protein families are both required for cell cycle progression in fibroblasts. Mol. Cell. Biol. 11: 4466-4472, 1991.
12. Lewis, J. F., and J. H. Jobe. Surfactant and the adult respiratory distress syndrome. Am. Reu. Respir. Dis. 147: 218-233, 1993.
13. Meduri, G. U. Late adult respiratory distress syndrome. New Horizons 1: 563-577, 1993
14. Mosmann, T. Rapid colormetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65: 55-63, 1980.
15. Murrell, G. A. C., M. J. O. Francis, and L. Bromley. Modulation of fibroblast proliferation by oxygen free radicals. Biochem. J. 265: 659-665, 1990.
16. Pison, U., U. Obertacke, M. Brand, W. Seeger, T. Joka, J. Bruch, and K. Schmit-Neuerburg. Altered pulmonary surfactant in uncomplicated and septicemia-complicated courses of adult respiratory failure. J. Trauma 30: 19-26, 1990.
17. Pison, U., W. Seeger, R. Buchhorn, T. Joka, M. Brand, U. Obertacke, H. Neuhof, and K. Schmit-Neuerburg. Surfactant abnormalities in patients with respiratory failure after multiple trauma. Am. Rev. Respir. Dis. 140: 1033-1039, 1989.
18. Puzas, J. E., and J. S. Brand. The effect of bone cell stimulatory factors can be measured with thymidine incorporation only under specific conditions. Calcif. Tissue Int. 39: 104-108, 1986.
19. κB. In: Oxidative Stress, Cell Activation and Viral Infection, edited by C. Pasquier, R. Y. Olivier, C. Auclair, and L. Packer. Boston, MA: Birkhauser Verlag, 1994, p. 77-90.
20. Repine, J. E. Scientific perspectives on adult respiratory distress syndrome. Lancet 339: 466-469, 1992.
21. Repine, J. E., and P. E. Parsons. Oxidant-antioxidant balance in endotoxin-induced oxidative injury and tolerance to oxidative injury. In: Endotoxin and the Lungs, edited by K. L. Brigham. New York: Marcel Dekker, 1994, p. 207-227.
22. Rinaldo, J. E., and J. W. Christman. Mechanisms and mediators of the adult respiratory distress syndrome. Clin. Chest Med. 11: 621-632, 1990.
23. Robinson, P. C., L. C. Watters, T. E. King, and R. J. Mason. Idiopathic pulmonary fibrosis: abnormalities in bronchoalveolar lavage fluid phospholipids. Am. Rev. Respir. Dis. 137: 585-591, 1988.
24. Seeger, W., U. Pison, R. Buchhorn, U. Obertacke, and T. Joka. Surfactant abnormalities and adult respiratory failure. Lung 168: 891-902, 1990.
25. Sherr, C. J. Mammalian G1 cyclins. Cell 73: 1059-1065, 1993.
26. Simon, R. H., and P. A. Ward. Adult respiratory distress syndrome. In: Inflammation:Basic Principles and Clinical Correlates, edited by J. I. Gallin, I. M. Goldstein, and R. Synderman. New York: Raven, 1992, p. 999-1016.
27. Speer, C. P., B. Gotze, T. Curtstedt, and B. Robertson. Phagocytic functions and tumor necrosis factor secretion of human monocytes exposed to natural porcine surfactant (Curosurf). Pediatr. Res. 30: 69-74, 1991.
28. Spragg, R. G., and R. M. Smith. Surfactant as therapy for ARDS. In: Endotoxin and the Lung, edited by K. L. Brigham. New York: Marcel Dekker, 1994, p. 393-423.
29. Thomassen, M. J., J. M. Antal, M. J. Connors, D. P. Meeker, and H. P. Wiedemann. Characterization of Exosurf (surfactant)-mediated suppression of stimulated human alveolar macrophage cytokine responses. Am. J. Respir. Cell Mol. Biol. 10: 399-404, 1994.
30. Thomassen, M. J., J. M. Antal, L. T. Divis, and H. P. Wiedemann. Pulmonary surfactant suppresses production of inflammatory mediators by human alveolar macrophages and lung parenchymal cells (Abstract). Cytokine 6: 550, 1994.
31. Thomassen, M. J., D. P. Meeker, J. M. Antal, M. J. Connors, and H. P. Wiedemann. Synthetic surfactant (Exosurf) inhibits endotoxin-stimulated cytokine secretion by human alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 7: 257-260, 1992.
32. Thor, H., M. T. Smith, P. Hartzell, G. Bellomo, S. A. Jewell, and S. Orrenius. The metabolism of menadione (2-methyl-1,4-naphthoquinone) by isolated hepatocytes. J. Biol. Chem. 257: 12419-12425, 1982.
33. Tomashefski, J. F. Pulmonary pathology of the adult respiratory distress syndrome. Clin. Chest Med. 11: 593-619, 1990.